膝关节假体周围感染两阶段治疗的相关并发症与结局
该回顾性研究分析了学术转诊中心98例感染膝行两阶段治疗的结果,并与专科感染中心134例比较。本队列82%患者再植入后1年内无需再手术即获成功,高于比较研究的56%;99%患者进入第二阶段,高于比较研究的91.8%;长期间隔物保留为0例,比较研究为4.5例;两阶段间再手术率相似,本队列再植入后1年内再手术更少;本队列医疗并发症率更高,但两阶段间及再植入后1年内无死亡,比较研究有6例死亡。作者认为差异可能反映患者群体复杂性及围手术期和手术方案差异,而非两阶段治疗本身。
要点
- 本队列82%患者再植入后1年内无需再手术即获成功,比较研究为56%。
- 本队列99%患者进入第二阶段,比较研究为91.8%;长期间隔物保留为0例,比较研究为4.5例。
- 本队列医疗并发症率更高,但两阶段间及再植入后1年内无死亡,比较研究有6例死亡。
核心结论
- 观察到的差异可能反映该患者群体固有的复杂性以及围手术期和手术方案的差异,而非两阶段治疗本身。
- 在讨论两阶段与单阶段治疗膝关节感染的相对并发症率时,应考虑两阶段治疗相关并发症的队列特异性。
研究设计与样本
- 回顾性分析学术转诊中心98例感染膝行两阶段治疗的病历数据。
- 与专科假体周围关节感染中心134例感染膝的比较研究结果进行对比。
主要发现
- 本队列82%患者再植入后1年内无需再手术即获成功,比较研究为56%。
- 本队列99%患者进入第二阶段,比较研究为91.8%;长期间隔物保留为0例,比较研究为4.5例。
- 两阶段间再手术率相似,本队列再植入后1年内再手术更少。
- 本队列医疗并发症率更高,患者表面上病情更重。
- 两阶段间及再植入后1年内无死亡,比较研究有6例死亡;最新平均随访49.0个月时报告最终患者结局。
关键数值与推荐
- 本队列98例感染膝,比较研究134例感染膝。
- 本队列82%患者再植入后1年内无需再手术即获成功,比较研究为56%。
- 本队列99%患者进入第二阶段,比较研究为91.8%。
- 本队列长期间隔物保留为0例,比较研究为4.5例。
- 本队列两阶段间及再植入后1年内无死亡,比较研究有6例死亡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent studies have focused on morbidity during the interstage and early post reimplantation periods of two-stage treatment for periprosthetic joint infection, suggesting that single-stage treatment may alleviate high complication rates. To understand the possibly cohort-specific nature of complications associated with two-stage treatment, we compared morbidity in an independent cohort using the same methods as a comparison study. METHODS: We retrospectively analyzed medical chart data for 98 infected knees undergoing two-stage treatment at our academic referral center. The results were compared to the outcomes of 134 infected knees in a comparison study performed at a specialized periprosthetic joint infection center. Outcomes included reoperations and medical complications during the interstage period and within 1 year of reimplantation, along with final patient dispositions at the latest mean follow-up of 49.0 months. RESULTS: In the current sample, 82% of patients achieved successful reimplantation without reoperation within a year compared to 56% in the comparison study. There were 99% of patients, compared to 91.8%, who progressed to the second stage of treatment, with concomitantly fewer instances of long-term spacer retention (0 versus 4.5%). Interstage reoperations were similar, although there were fewer reoperations within a year of reimplantation in the current cohort. Medical complication rates were higher in the current study, which comprised ostensibly sicker patients. There were no deaths during the interstage period or within a year of reimplantation, compared to six deaths in the comparison study. CONCLUSIONS: Observed differences may reflect the inherent complexity of this patient group, as well as perioperative and surgical protocol differences, and not the two-stage treatment itself. The cohort-specific nature of morbidity associated with two-stage treatment should be considered in discussions about the relative morbidity of two-stage versus single-stage treatment for knee infection.
引用
- Thomas JJ, Ziemba-Davis M, Buller LT, et al. Complications and Outcomes Associated With Two-Stage Treatment of Periprosthetic Knee Infection. J Arthroplasty. 2025. PMID: 40570988. doi:10.1016/j.arth.2025.06.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。